Quest looks to buy again ... ... but analysts say it might be one too many.(The Week in Healthcare)(Quest Diagnostics Inc. (San Juan Capistrano, California) acquires AmeriPath Inc.)

Modern Healthcare, April, 2007 by Rhea, Shawn

Byline: Shawn Rhea

Quest Diagnostics has once again narrowed the field of independent laboratories with its announcement last week that it would buy AmeriPath, a company specializing in cancer diagnosis, for $2 billion, raising concerns among hospitals offering laboratory services.

The deal comes on the heels of Quest's acquisition of the point-of-care testing company HemoCue for $420 million on Jan. 31.

"The acquisition will accelerate Quest Diagnostics' earning growth and provide compelling benefits for patients, physicians, hospitals and payers,'' said Surya Mohapatra, chairman and chief executive officer of Quest.

The deal is expected to close in the second quarter and is subject to clearance from the Federal Trade Commission....

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement